Call(WhatsApp Us)
+8615360806100Email Us
cherry@laeyo.comSee the factory by live video walkthrough
Book an on-site factory visit in GuangzhouA baby care shipment is not released by a purchase order. It is released by a signed handover file — a set of approvals, test reports, and physical reference samples that prove the product…
A baby care shipment is not released by a purchase order. It is released by a signed handover file — a set of approvals, test reports, and physical reference samples that prove the product inside the container is the product you approved. Because mom and baby care sits in the highest-scrutiny segment of personal care, the gap between “the samples looked great” and “the first shipment is releasable” is almost always documentation, not formula. This guide sets out the sign-offs to collect before the first shipment, what each one must prove, and the failure modes that usually only surface after the container has sailed.
A handover sign-off is not a courtesy signature on a shipping document. It is a three-layer confirmation, and each layer has a different owner:
Practically, the handover page should carry signatures and dates from seven functions: project manager, R&D, production, quality/regulatory, purchasing/packaging, warehouse/logistics, and the final approver. If any of those boxes is signed by the same person “to save time,” the control has been removed, not streamlined.
Most handover problems are created weeks earlier by leaving three decisions open too long. Sequence them deliberately:
Fastest safe path: lock formula direction, package route, and the claim list first; keep fragrance level, graphics, and secondary packaging as the later optimization levers. Those three can move without invalidating the micro, stability, or compatibility data. Formula and pack cannot.
| Sign-off | What it proves | Who signs | Evidence to file |
|---|---|---|---|
| Formula and specification lock | The batch was made to a fixed, versioned target | R&D + QA | Signed spec sheet with revision code, pH, viscosity, actives, and effective date |
| Golden sample and pack combo approval | Physical reference exists for comparison at any future reorder | Buyer + R&D/QA | Sealed retained sample, photos, component drawings, combo ID |
| Packaging compatibility and transit test | Product and pack survive real use and real shipping | Packaging supplier + QA | Compatibility report (leak, pump/dropper function, label adhesion, weight loss) plus drop, compression, and high-temperature transit results |
| Artwork and label proof approval | The printed label matches the approved formula version | Regulatory + Buyer | Final approved PDF with revision code, approval date, and print-proof photo |
| Claims substantiation matrix | Every on-pack and listing claim has a test behind it | Regulatory | Claim-to-evidence table mapping each claim to a report number and date |
| Preservative efficacy and microbiology | The product stays safe through use, not just at release | Third-party lab | Challenge test report, finished-product micro results, specification limits |
| Stability and shelf-life assignment | The declared expiry date is supported by data, not assumption | Lab + QA | Accelerated and real-time protocol, interim report, signed shelf-life statement and storage conditions |
| Product safety assessment | The formula has been assessed by a qualified safety assessor for the target market | Safety assessor / Regulatory | Signed safety report or product information file index, with assessor credentials |
| Batch record and QA release decision | Nothing was shipped while a deviation or out-of-spec result was open | Production + QA | Executed batch record, deviation log, OOS/OOT status, traceability result, written release (not “hold”) decision |
| First article inspection and line clearance | The filling line was verified before continuous production | Production + QA | FAI record covering SKU, formula, components, artwork, line clearance, fill weight, seal and appearance checks |
| Documentation pack and retained samples | The brand can answer an auditor, a marketplace, or a customs officer later | QA + Logistics | COA per batch, SDS, invoice, packing list, batch-code traceability map, retention location and retention period |
Informational only, not legal advice. Confirm market-specific obligations with your regulatory specialist or responsible person.
Subject: Pre-shipment handover pack – [Brand] / [PO number]
Share the locked formula and specification sheet with revision code and effective date.
Confirm the production component supplier, version, and drawing for bottle, pump, cap, and lid.
Provide the packaging compatibility report covering leak, dispensing function, and label adhesion.
Attach the drop, compression, and high-temperature transit test results.
Provide the preservative efficacy (challenge) test report and finished-product micro results.
Attach the stability protocol, interim report, and signed shelf-life and storage statement.
Provide the product safety assessment or product information file index for the target market.
Attach the claims substantiation matrix linking each claim to a report number.
Send the final approved artwork PDF with revision code and approval date.
Confirm the label review covers required language, responsible party, net content, and allergens.
Provide the executed batch record summary and line clearance record for this batch.
Confirm zero open deviations and zero open out-of-specification results.
State the QA release decision in writing (release or hold) with the approver name and date.
Attach the first article inspection record, including fill weight and seal checks.
Provide a batch-specific COA and the SDS for the finished product.
Send the batch-code traceability map linking components, bulk, filling, and cartons.
Confirm where retained samples are stored and the retention period.
List the shipping documents included in the carton and the contact for discrepancies.
Confirm which documents remain the brand's responsibility in the destination market.
Confirm the reorder lead time and the process for re-approval if any component changes.
Fastest safe path: run testing in parallel with pilot production and compress artwork rounds by freezing claims early — but do not compress the stability read-out, the challenge test, or the first article inspection. Standard path: sequence pilot, then testing, then label approval, which adds roughly three to four weeks and materially lowers the risk of a reprint or a held shipment.
Only with a documented, dated stability protocol, an interim accelerated report showing no failure, and a signed shelf-life assignment with a commitment to complete real-time data. Shipping with no stability data at all means the expiry date on pack is a guess, and that is difficult to defend if a customer or regulator asks.
Project management, R&D, production, quality/regulatory, purchasing or packaging, warehouse/logistics, and the final approver — each with a signature and a date. Consolidating these into one signature removes exactly the cross-checks the page exists to create.
For U.S. cosmetics, identify the label-defined responsible person and assess required facility registration and product listing, including applicable exemptions. A foreign facility required to register must designate a U.S. agent. The European Union centres on an EU responsible person, product notification before placing on the market, a product information file with a safety report, and GMP compliance. The factory typically supplies formula, safety, and batch documentation; the brand or importer typically owns the responsible-person role, notification, and final market-facing label. Never present a notification or listing as a certification or approval.
Ask for the written retention policy rather than a verbal answer, and align it to the strictest market you sell into — the EU, for example, expects the product information file to remain available for ten years after the last batch is placed on the market. Retained samples should cover at least the declared shelf life plus a margin, stored under labelled conditions.
Release batch by batch, not order by order. Each SKU should carry its own QA release decision, its own COA, and its own document reconciliation. Partial shipment is acceptable; partial documentation is not.
If you are sourcing baby wash, creams, wipes, or a mom-and-baby gifting set and want a handover pack built into the project plan from day one, start with a scoped request. Include your target market and responsible-entity plan, SKU count and formats, positioning (for example fragrance-free, tear-free, or clean-label), packaging direction (stock, semi-custom, or custom mold), and your launch window — those five inputs are what turn a general enquiry into a costed, test-planned quote. Request a Quote and ask for the pre-shipment handover checklist to be attached to your project brief.
Official sources: FDA registration and listing guidance.